India's Biocon reported a huge fiscal year for its CRO arm, growing 36% over the previous year and becoming the largest clinical research provider in the country, the company said.
The Japanese drugmaker will use the plant to tap growing demand in that country, as well as an export base for other emerging markets in Asia.
CardioDx, a 2012 Fierce 15 winner, has partnered with India's Core Diagnostics to distribute its coronary artery disease test in the country's burgeoning market.
Drugmakers from around the world are hustling to expand in China's fast-growing drug market. Merck just opened a $120 million packaging plant there and now Japan's Eisai is set to build a new plant to make parenteral products in Suzhou, Jiangsu.
Four years ago, a federal agency in Thailand began building a plant intended to produce enough flu vaccine to protect the country in case of a pandemic. But anticorruption investigators for the current government now want answers as to why the plant is two years overdue.
India's government wants the country to become the world's preeminent low-cost vaccine supplier, but it will first have to overcome problems of its own making.
South Africa plans to revamp its intellectual-property laws to make it more difficult for pharma companies to win protection for new versions of older drugs. The move comes soon after India's top court backed strict requirements for drug patents.
Electrophysiology devices (think ablation catheters and medical lasers) should reach $4.4 billion in global sales by 2015 as the sector approaches nearly double-digit growth, concludes a new industry report.
Medtronic CEO Omar Ishrak has made no secret of how important emerging markets are to his company's growth, and India's swelling population and expanding medical access are key to the device giant's future, he said.
India's government is struggling to crack down on loosely regulated clinical trials that have killed hundreds of patients around the country, and while it's unclear if its efforts have made the process safer, they've certainly slowed things down.